Previous Close | 1.0930 |
Open | 1.1118 |
Bid | 1.1112 x N/A |
Ask | 1.2202 x N/A |
Day's Range | 1.1118 - 1.1118 |
52 Week Range | 0.9395 - 3.3420 |
Volume | |
Avg. Volume | 0 |
Market Cap | 895.791M |
Beta (5Y Monthly) | 1.70 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1700 |
Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.60 |
Subscribe to Yahoo Finance Plus to view Fair Value for XCY.F
Does the January share price for OPKO Health, Inc. ( NASDAQ:OPK ) reflect what it's really worth? Today, we will...
MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023 at the Westin St. Francis in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 11th at 4:30 p.m. Pacific time. The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s we
Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in RAYALDEE.